Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices

Last updated: November 19, 2024
Sponsor: Swinburne University of Technology
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tourette's Syndrome

Deafness

Tinnitus

Treatment

Cognitive behavioural therapy (CBT)

Avatar therapy

Clinical Study ID

NCT05982158
GNT2015133
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to compare the effects of a new psychological therapy, Avatar Therapy, to the current standard therapy, Cognitive Behavioural Therapy (CBT), in improving outcomes in people living with psychotic disorders who have persisting experiences of hearing voices (auditory verbal hallucinations, AVHs).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Schizophrenia-related disorder or a mood disorder with psychotic symptoms diagnosisconfirmed using the Structured Clinical Interview for DSM (SCID)

  • Experiencing current auditory verbal hallucinations as measured by the Positive andNegative Syndrome Scale (PANSS) item P3 ≥ 4

  • Auditory verbal hallucinations present for at least one year

  • AVHs include significant negative content (PSYRATS item 6 ≥ 2) and/or AVHs aredistressing (PSYRATS item item 9 ≥ 2)

  • Current treatment with antipsychotic medication, or has been treated withantipsychotic medication in the past, with at least two different antipsychoticcompounds, and these have been discontinued due to insufficient treatment responseand/or poor tolerability.

  • Access to the internet and a computer or other device on which videoconferencingsoftware can be used

  • Sufficient fluency in English for meaningful participation

  • Age 18 or over

  • Ability to give informed consent

Exclusion

Exclusion Criteria:

  • Auditory verbal hallucinations attributable to a primary substance use disorder ororganic disorder

  • Estimated full scale IQ < 70 (using the Test of Premorbid Functioning, TOPF)

  • Within the last month or planned at the time of intake: a change of antipsychoticmedication,

  • Current or within the past 3 months receipt of individual psychological therapy forhearing voices, or receipt of electro-convulsive therapy or other brain stimulationtreatment;

  • AVHs in a language not spoken by the therapists.

Study Design

Total Participants: 212
Treatment Group(s): 2
Primary Treatment: Cognitive behavioural therapy (CBT)
Phase:
Study Start date:
August 08, 2023
Estimated Completion Date:
June 30, 2027

Study Description

Continually hearing critical, abusive or threatening voices (auditory verbal hallucinations, AVHs) is a major persisting and disabling symptom of psychotic disorders such as schizophrenia. Current treatments have universally had only modest impact. In preliminary trials, a brief digitally supported treatment, using avatars to recreate AVHs during therapy, has produced some of the largest reductions in AVH severity seen to date. To definitively test the superiority of this innovative treatment, AMETHYST is a randomised controlled trial comparing avatar therapy to current recommended best practice treatment, CBT, for medication-resistant AVHs.

Connect with a study center

  • Swinburne University of Technology

    Hawthorn, Victoria 3122
    Australia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.